Updates in the Management of Myeloproliferative Neoplasms

home / peer-exchange / updates-in-the-management-of-myeloproliferative-neoplasms
Characterization of Myeloproliferative Neoplasms

EP. 1: Characterization of Myeloproliferative Neoplasms

July 7th 2020
Polycythemia Vera: Diagnostic Work-up

EP. 2: Polycythemia Vera: Diagnostic Work-up

July 7th 2020
Polycythemia Vera: Bone Marrow Biopsies

EP. 3: Polycythemia Vera: Bone Marrow Biopsies

July 7th 2020
Polycythemia Vera: Prognostic Markers

EP. 4: Polycythemia Vera: Prognostic Markers

July 7th 2020
Polycythemia Vera: Risk Assessment

EP. 5: Polycythemia Vera: Risk Assessment

July 7th 2020
Polycythemia Vera: Monitoring Patients

EP. 6: Polycythemia Vera: Monitoring Patients

July 7th 2020
Management of Low-Risk Polycythemia Vera

EP. 7: Management of Low-Risk Polycythemia Vera

July 7th 2020
Treatment Options for High-Risk Polycythemia Vera

EP. 8: Treatment Options for High-Risk Polycythemia Vera

July 7th 2020
Polycythemia Vera: Switching Therapy

EP. 9: Polycythemia Vera: Switching Therapy

July 7th 2020
Polycythemia Vera: Ruxolitinib Trial Data

EP. 10: Polycythemia Vera: Ruxolitinib Trial Data

July 7th 2020
Utilization of Ruxolitinib for Polycythemia Vera

EP. 11: Utilization of Ruxolitinib for Polycythemia Vera

July 7th 2020
Polycythemia Vera: PROUD-PV Trial

EP. 12: Polycythemia Vera: PROUD-PV Trial

July 7th 2020
Primary Myelofibrosis: Risk Stratification

EP. 13: Primary Myelofibrosis: Risk Stratification

July 7th 2020
Management of Low-Risk Primary Myelofibrosis

EP. 14: Management of Low-Risk Primary Myelofibrosis

July 7th 2020
Treating Intermediate/High-Risk Primary Myelofibrosis

EP. 15: Treating Intermediate/High-Risk Primary Myelofibrosis

July 7th 2020
Ruxolitinib for Primary Myelofibrosis

EP. 16: Ruxolitinib for Primary Myelofibrosis

July 7th 2020
Ruxolitinib and Surgical Interventions

EP. 17: Ruxolitinib and Surgical Interventions

July 7th 2020
Fedratinib for Primary Myelofibrosis

EP. 18: Fedratinib for Primary Myelofibrosis

July 7th 2020
JAK2 Inhibitor Selection for Primary Myelofibrosis

EP. 19: JAK2 Inhibitor Selection for Primary Myelofibrosis

July 7th 2020
Primary Myelofibrosis: Trials of Interest

EP. 20: Primary Myelofibrosis: Trials of Interest

July 7th 2020
Classifying Patients With Essential Thrombocythemia

EP. 21: Classifying Patients With Essential Thrombocythemia

July 7th 2020
Essential Thrombocythemia: Treatment Optimization

EP. 22: Essential Thrombocythemia: Treatment Optimization

July 7th 2020
Advances in the Management of MPNs

EP. 23: Advances in the Management of MPNs

July 7th 2020